Hoth Therapeutics Inc is a biotechnology business based in the US. Hoth Therapeutics shares (HOTH) are listed on the NASDAQ and all prices are listed in US Dollars. Hoth Therapeutics employs 3 staff and has a market cap (total outstanding shares value) of 0.00.
Our top pick for
Active traders
Our top pick for
Beginners
Our top pick for
Building a portfolio
| Latest market close | $0.81 |
|---|---|
| 52-week range | $0.64 - $3.50 |
| 50-day moving average | $0.88 |
| 200-day moving average | $1.28 |
| Wall St. target price | $3.88 |
| PE ratio | N/A |
| Dividend yield | N/A (0%) |
| Earnings per share (TTM) | $-0.59 |
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Historical closes compared with the close of $0.81 from 2022-01-14
| 1 week (2022-01-07) | -14.98% |
|---|---|
| 1 month (2021-12-16) | 15.22% |
| 3 months (2021-10-15) | -30.17% |
| 6 months (2021-07-16) | -41.30% |
| 1 year (2021-01-15) | -63.18% |
|---|---|
| 2 years (2020-01-17) | -83.85% |
| 3 years (2019-01-13) | N/A |
| 5 years (2017-01-13) | N/A |
| Gross profit TTM | $0 |
|---|---|
| Return on assets TTM | -68.15% |
| Return on equity TTM | -123.81% |
| Profit margin | 0% |
| Book value | $0.56 |
| Market capitalisation | $22.8 million |
TTM: trailing 12 months
We're not expecting Hoth Therapeutics to pay a dividend over the next 12 months.
Over the last 12 months, Hoth Therapeutics's shares have ranged in value from as little as $0.635 up to $3.5. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Hoth Therapeutics's is 0.9852. This would suggest that Hoth Therapeutics's shares are less volatile than average (for this exchange).
Hoth Therapeutics, Inc. , a biopharmaceutical company, focuses on developing therapies for dermatological disorders. The company focuses on therapies for patients suffering from indications, including eczema, chronic wounds, psoriasis, asthma, and acne. Its pipeline portfolio includes HT-001, a topical formulation for the treatment of mild to moderate rash and skin disorders associated with initial and repeat courses of tyrosine kinase inhibitor/epidermal growth factor receptor (EGFR) inhibitor therapy; HT-002 to treat illness associated with SARS-CoV-2 infection; HT-003D for the topical treatment in acne and psoriasis applications; HT-003IB to treat inflammatory bowel diseases; HT-004 for the treatment of asthma, atopic dermatitis, and other allergic diseases; HT-005 Z-PODS to treat cutaneous lupus erythematosus; HT-006 for treatment of multiple bacterial pathogens. The company has license agreements with the George Washington University; the University of Maryland; Isoprene Pharmaceuticals, Inc. ; the North Carolina State University; Chelexa BioSciences, Inc. ; and the University of Cincinnati.
Donut earns up to 10% APY, but you must have an iOS device.
We’ve rounded up stats on some of the most popular COVID test stocks, along with information on how they compare and how to invest.
Buffett’s Berkshire Hathaway may now be on its way to becoming the next trillion-dollar company.
Everything we know about the Affinia Therapeutics IPO, plus information on how to buy in.
Everything we know about the Austin Gold IPO, plus information on how to buy in.
Everything we know about the VinFast IPO, plus information on how to buy in.
Creating a golf club is a thus-far unique application of NFTs, and another step forward for the decentralized economy.
Everything we know about the Nexalin Technology IPO, plus information on how to buy in.
Everything we know about the Specialty Building Products IPO, plus information on how to buy in.
Everything we know about the HeartCore Enterprises IPO, plus information on how to buy in.